Solstice Biologics raises $4M – but where did CEO Lou Tartaglia go?
After one year at biotech startup Solstice Biologics, Third Rock vet Lou Tartaglia's back in venture land - having joined 5AM Ventures.
That RNAi startup whose founder was shot by a disgrunted biotech exec just raised $7.5M
Solstice Biologics, an interesting RNAi therapeutics company that has attracted attention for the wrong reasons, has raised $7.5 million, according to a regulatory filing, building on the $18 million raised last year from venBio and Aeris Capital. The San Francisco company is figuring out how to get RNAi-based drugs to cross multiple cell types to treat different […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The lucky ones: Check out Timmerman’s list of biotech startups funded in 2013
Luke Timmerman at Xconomy crunched the biotech funding numbers for this year to compile a class of 2013 list. You won’t be surprised that he found things haven’t been this bad since 1996: There were only 102 first-time financings of life sciences companies through the first nine months of 2013, the lowest amount since 1996, […]